Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS)

MDS Rating Scales

Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS)


Acronym: PSP-CDS

Authors: Günter U. Höglinger, Ines Piot, Kerstin Schweyer, Gesine Respondek, Maria Stamelou, Philipp Sckopke, Thomas Schenk, Christopher G. Goetz, and Glenn T. Stebbins

The PSP-CDS was developed to assess clinical deficits in patients with Progressive Supranuclear Palsy (PSP). The scale measures severity of deficits in seven patient-relevant clinical domains: Akinesia-rigidity, Bradyphrenia, Communication, Dysphagia, Eye movements, Finger dexterity, and Gait & balance; each scored from 0 to 3.

With good sensitivity to change and well-defined clinical domains, the PSP-CDS is a valid and reliable scale that can be easily applied to a broad spectrum of PSP phenotypes equally.

This scale is expected to be useful for clinical care and research involving PSP, including observational and therapeutic trials relating to hallmark and variant PSP phenotypes.

View the Scale (PDF)

To request permission to use this Rating Scale, please fill out a Permission Request Form.

Year Published: 2020

Assessment Type: ClinRO

Estimated Time to Complete: 4 minutes

Available Translations: None

Publications:

Piot I, Schweyer K, Respondek G, Stamelou M, Sckopke P, Schenk T, Goetz CG, Stebbins GT. Höglinger GU, and members of the DescribePSP study group, ProPSP study group, and MDS-endorsed PSP study group. The Progressive Supranuclear Paksy Clinical Deficits Scale. Movement Disorders. 2020 Jan; https://doi.org/10.1002/mds.27964
(Original Scale Publication)

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice